The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

Keyphrases

• Renal Cell Carcinoma 100%
• Subtype-specific 100%
• Molecular Characterization 100%
• Cancer Genome Atlas 100%
• Cyclin-dependent Kinase Inhibitor 2A (CDKN2A) 50%
• Therapeutic Strategies 50%
• Somatic Alterations 50%
• DNA Hypermethylation 50%
• Chromophobe Renal Cell Carcinoma (chRCC) 50%
• Histological Subtypes 50%
• BRCA1-associated Protein 1 (BAP1) 50%
• Distinctive Features 50%
• Immune Signature 50%
• PBRM1 50%
• Management Strategies 50%
• Metabolic Pathways 50%
• Renal Cell Carcinoma Subtypes 50%
• Genome Analysis 25%
• Expression Pattern 25%
• Clinical Treatment 25%
• Poor Survival 25%
• Gene Signature 25%
• Genetic Drivers 25%
• Therapeutic Response 25%
• Metabolic 25%
• Immune-related 25%
• Clinical Course 25%
• Clear Cell Renal Cell Carcinoma (ccRCC) 25%
• CIMP 25%
• Single Disease 25%
• Phenotypic Analysis 25%
• Papillary Renal Cell Carcinoma (pRCC) 25%

Biochemistry, Genetics and Molecular Biology

• DNA Methylation 100%
• BAP1 100%
• PBRM1 100%
• Cyclin Dependent Kinase Inhibitor 2A 100%
• Genetics 50%
• Gene Expression Profiling 50%
• Genomics 50%